You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IMC-001

Showing 1 - 25 of 858
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Anti-PD-L1 Monoclonal Antibody IMC-001
  • Punch Biopsy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Advanced Digestive System Tumor Trial in China (IMC001 injection)

Not yet recruiting
  • Advanced Digestive System Tumor
  • IMC001 injection
  • Beijing, Beijing, China
  • +6 more
Jul 12, 2023

Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +3 more
  • EPCAM CAR-T
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Jan 12, 2022

Solid Tumor, Metastasis, Locally Advanced Trial in Yongin-si (IMC-001)

Completed
  • Solid Tumor
  • +2 more
  • IMC-001
  • Yongin-si, Gyeonggi-do, Korea, Republic of
    ImmuneOncia
May 26, 2020

Subjects With Resectable and Localized Gastric Cancer, Subjects With Resectable Esophageal Cancer or Liver Cancer, Subjects With

Recruiting
  • Subjects With Resectable and Localized Gastric Cancer
  • +2 more
  • IMC-001
  • Seoul, Korea, Republic of
    Asan Medical Center
Dec 10, 2019

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Colorectal Adenocarcinoma, RAS Wild Type, Stage IV Colorectal Cancer AJCC v7 Trial in United States (biological, drug, other)

Completed
Has Results
  • Colorectal Adenocarcinoma
  • +4 more
  • Bevacizumab
  • +4 more
  • Scottsdale, Arizona
  • +12 more
Jan 27, 2022

Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)

Recruiting
  • Hepatitis B, Chronic
  • IMC-I109V-101 Single Ascending Dose
  • IMC-I109V-101 Multiple Ascending Doses
  • Los Angeles, California
  • +19 more
May 10, 2023

Myeloid Leukemia Trial in Columbus, Houston (IMC-EB10)

Terminated
Has Results
  • Myeloid Leukemia
  • IMC-EB10
  • Columbus, Ohio
  • +1 more
Dec 20, 2022

Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

Not yet recruiting
  • Advanced Melanoma
  • IMC-F106C
  • +2 more
  • La Jolla, California
  • +61 more
Oct 31, 2023

Using IMC to Analyze the Impact of ICANS on Microglia

Recruiting
  • ICANS, Grade Unspecified
  • CAR T-Cell-Related Encephalopathy Syndrome
  • There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
  • Freiburg, Baden Württemberg, Germany
    Freiburg University Medical Center
Apr 12, 2023

Breast Cancer Trial in Worldwide (biological, drug, other)

Completed
Has Results
  • Breast Cancer
  • ramucirumab (IMC-1121B)
  • +2 more
  • Birmingham, Alabama
  • +232 more
Nov 3, 2021

Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

Completed
  • Safety
  • +2 more
  • RHN-001 (one tablet 750mg)
  • RHN-001 (750mg * 2 Tablets)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023

Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

Not yet recruiting
  • Acneiform Eruption Due to Chemical
  • +2 more
  • HT-001 2% Topical Gel
  • +3 more
  • (no location specified)
Dec 3, 2022

Malignant Solid Tumor Trial in United States (ramucirumab (IMC-1121B), paclitaxel)

Completed
Has Results
  • Malignant Solid Tumor
  • Ann Arbor, Michigan
  • +5 more
Feb 14, 2022

Advanced Solid Tumor Trial in Shanghai (B4T2-001 autologous CAR-T)

Recruiting
  • Advanced Solid Tumor
  • B4T2-001 autologous CAR-T
  • Shanghai, China/Shanghai, China
  • +1 more
Oct 3, 2023

l Gene Editing Therapy for Cardiovascular Disease

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +2 more
    • Auckland, New Zealand
    • +2 more
    Oct 31, 2023

    Non-Hodgkin Lymphoma Trial (CC-122, Dexamethasone)

    Not yet recruiting
    • Non-Hodgkin Lymphoma
    • (no location specified)
    Jan 10, 2023

    Meibomian Gland Dysfunction, Dry Eye Trial in Australia, Canada, New Zealand (AZR-MD-001 Low Dose, AZR-MD-001 Mid Dose,

    Completed
    • Meibomian Gland Dysfunction
    • Dry Eye
    • AZR-MD-001 Low Dose
    • +3 more
    • Chatswood, New South Wales, Australia
    • +29 more
    Nov 23, 2022

    Acute Cannabinoid Intoxication Trial in Leiden (ANEB-001, Placebo)

    Active, not recruiting
    • Acute Cannabinoid Intoxication
    • Leiden, ZH, Netherlands
      Centre for Human Drug Research (CHDR)
    Jan 31, 2023

    Cystinosis Trial (Cysteamine Bitartrate, N-Acetylcysteine Amide)

    Not yet recruiting
    • Cystinosis
    • Cysteamine Bitartrate
    • N-Acetylcysteine Amide
    • (no location specified)
    Aug 15, 2023

    Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

    Recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • CYNK-001 systemic and Intra cavity administration
    • Duarte, California
    • +5 more
    Jan 20, 2023

    Vaccine-Preventable Diseases, Herpes Zoster Trial in Seoul, Seongnam-si (CVI-VZV-001, Shingrix)

    Recruiting
    • Vaccine-Preventable Diseases
    • Herpes Zoster
    • CVI-VZV-001
    • Shingrix
    • Seoul, Eunpyeong-gu, Korea, Republic of
    • +1 more
    Nov 20, 2023

    Atopic Dermatitis Trial in Beijing (GD-iExo-001, normal saline)

    Recruiting
    • Atopic Dermatitis
    • Beijing, Beijing, China
      Chinese Academy of Medical Science & Peking Union Medical Colleg
    Jul 23, 2023

    Oral Mucositis Trial (RRx-001, Intensity Modulated Radiation Therapy (IMRT), Cisplatin for injection 100 mg/m2)

    Not yet recruiting
    • Oral Mucositis
    • (no location specified)
    Jul 31, 2023